Nervosave Therapeutics SAS
Based in Montpellier, France, Nervosave leads the group's research, intellectual property and international strategy.
Nervosave Therapeutics is a France-based biotechnology company advancing innovative approaches to peripheral nerve health. Our group combines scientific expertise in Europe with translational development capabilities in China.
Based in Montpellier, France, Nervosave leads the group's research, intellectual property and international strategy.
杭州神髓生物科技有限公司
Based in Hangzhou, Shensui supports translational development, clinical partnerships and operations in China.
Nervosave brings together deep expertise in peripheral nerve biology and experience in healthcare quality, risk management and company building.

Co-founder · Scientific leadership
INSERM researcher and ERC Consolidator Grant laureate, with more than 35 scientific publications, including work published in Science and Nature Communications. An internationally recognized specialist in peripheral nerves, Schwann cells and myelin biology, he brings decades of scientific expertise to Nervosave's therapeutic programs.

Co-founder · Operations & quality
Engineer and entrepreneur specializing in healthcare quality and risk management, and founder of two companies. Her experience includes work as an expert for the French National Authority for Health (HAS), bringing operational discipline, quality expertise and healthcare project execution to Nervosave.
Our programs span inherited peripheral neuropathies, neuropathic pain, nerve health for intensive digital users, hearing health and veterinary applications. Our investigational gene-delivery platform is designed for targeted local administration.
Explore our programs →